SEARCH

SEARCH BY CITATION

References

  • 1
    Brott TG, Haley EC Jr, Levy DE et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23:63240.
  • 2
    Haley EC Jr, Levy DE, Brott TG et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke 1992; 23:6415.
  • 3
    Hacke W, Donnan G, ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:76874.
  • 4
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:15817.
  • 5
    Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, Del Zoppo GJ: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Am J Neuroradiol 1993; 14:313.
  • 6
    Mori E, Yoneda Y, Tabuchi M et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42:97682.
  • 7
    Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28:211925.
  • 8
    Flaherty ML, Woo D, Kissela B et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005; 64:3868.
  • 9
    Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM: Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002; 50:2519; discussion 259–60.
  • 10
    Ernst R, Pancioli A, Tomsick T et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 2000; 31:25527.
  • 11
    Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004; 35:90411.
  • 12
    The IMS II Investigators: Preliminary results of IMS II trial. Stroke 2006; 37:708.
  • 13
    Hill MD, Barber PA, Demchuk AM et al. Acute intravenous–intra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002; 33:27982.
  • 14
    Smith WS, Sung G, MERCI Trial Investigators et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36:14328.
  • 15
    Smith WS.: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. Am J Neuroradiol 2006; 27:117782.
  • 16
    Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282:200311.
  • 17
    Khatri P, Wechsler LR, Broderick JP.: Intracranial hemorrhage associated with revascularization therapies. Stroke 2007; 38:44150.